Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040
| Autor: | El-Khoueiry, A.B., Trojan, J., Meyer, T., Yau, T., Melero, I., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Kang, Y.-K., Yeo, W., Chopra, A., Soleymani, S., Yao, J., Neely, J., Tschaika, M., Welling, T.H., Sangro, B. |
|---|---|
| Zdroj: | In Annals of Oncology April 2024 35(4):381-391 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|